The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Custom Assays-Global Market Insights and Sales Trends 2024
Synopsis
Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes.
The global Custom Assays market size is expected to reach US$ 51450 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Custom Assays in various end use industries. The expanding demands from the Academic & Research Institutes, Biopharmaceutical Companies, Diagnostic Centers and Contract Research Organizations, are propelling Custom Assays market. Activity Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Competitive Assays segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Custom Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Custom Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Custom Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Custom Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Custom Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Custom Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Custom Assays covered in this report include Thermo Fisher Scientific, Bio-Rad, Roche Life Science, Fluidigm, Promega, Merck, GE Healthcare Lifescience, Cisbio and Biosensorix, etc.
The global Custom Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience
Global Custom Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Custom Assays market, Segment by Type:
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others
Global Custom Assays market, by Application
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Custom Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Custom assay is a type of cell or biochemical base provided by assay kits manufacturers to their customers when requested in order to fulfill their needs and purposes.
The global Custom Assays market size is expected to reach US$ 51450 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Custom Assays in various end use industries. The expanding demands from the Academic & Research Institutes, Biopharmaceutical Companies, Diagnostic Centers and Contract Research Organizations, are propelling Custom Assays market. Activity Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Competitive Assays segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Custom Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Custom Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Custom Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Custom Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Custom Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Custom Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Custom Assays covered in this report include Thermo Fisher Scientific, Bio-Rad, Roche Life Science, Fluidigm, Promega, Merck, GE Healthcare Lifescience, Cisbio and Biosensorix, etc.
The global Custom Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Bio-Rad
Roche Life Science
Fluidigm
Promega
Merck
GE Healthcare Lifescience
Cisbio
Biosensorix
ProeoGenix
Ethos Biosciences
Abzena
Agena Bioscience
Agilent
TissueMetrics
Eurofins Scientific
BioGenes GmbH
Eve Technologies
Quansys Bioscience
Global Custom Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Custom Assays market, Segment by Type:
Activity Assays
Competitive Assays
ELISA Assays
Screening Assays
Others
Global Custom Assays market, by Application
Academic & Research Institutes
Biopharmaceutical Companies
Diagnostic Centers
Contract Research Organizations
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Custom Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Custom Assays
1.1 Custom Assays Market Overview
1.1.1 Custom Assays Product Scope
1.1.2 Custom Assays Market Status and Outlook
1.2 Global Custom Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Custom Assays Market Size by Region (2018-2029)
1.4 Global Custom Assays Historic Market Size by Region (2018-2023)
1.5 Global Custom Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Custom Assays Market Size (2018-2029)
1.6.1 North America Custom Assays Market Size (2018-2029)
1.6.2 Europe Custom Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Custom Assays Market Size (2018-2029)
1.6.4 Latin America Custom Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Custom Assays Market Size (2018-2029)
2 Custom Assays Market by Type
2.1 Introduction
2.1.1 Activity Assays
2.1.2 Competitive Assays
2.1.3 ELISA Assays
2.1.4 Screening Assays
2.1.5 Others
2.2 Global Custom Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Custom Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Custom Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Custom Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Custom Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Custom Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Custom Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Custom Assays Revenue Breakdown by Type (2018-2029)
3 Custom Assays Market Overview by Application
3.1 Introduction
3.1.1 Academic & Research Institutes
3.1.2 Biopharmaceutical Companies
3.1.3 Diagnostic Centers
3.1.4 Contract Research Organizations
3.1.5 Others
3.2 Global Custom Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Custom Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Custom Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Custom Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Custom Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Custom Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Custom Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Custom Assays Revenue Breakdown by Application (2018-2029)
4 Custom Assays Competition Analysis by Players
4.1 Global Custom Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Custom Assays as of 2022)
4.3 Date of Key Players Enter into Custom Assays Market
4.4 Global Top Players Custom Assays Headquarters and Area Served
4.5 Key Players Custom Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Custom Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Custom Assays Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Custom Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Bio-Rad
5.2.1 Bio-Rad Profile
5.2.2 Bio-Rad Main Business
5.2.3 Bio-Rad Custom Assays Products, Services and Solutions
5.2.4 Bio-Rad Custom Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Recent Developments
5.3 Roche Life Science
5.3.1 Roche Life Science Profile
5.3.2 Roche Life Science Main Business
5.3.3 Roche Life Science Custom Assays Products, Services and Solutions
5.3.4 Roche Life Science Custom Assays Revenue (US$ Million) & (2018-2023)
5.3.5 Fluidigm Recent Developments
5.4 Fluidigm
5.4.1 Fluidigm Profile
5.4.2 Fluidigm Main Business
5.4.3 Fluidigm Custom Assays Products, Services and Solutions
5.4.4 Fluidigm Custom Assays Revenue (US$ Million) & (2018-2023)
5.4.5 Fluidigm Recent Developments
5.5 Promega
5.5.1 Promega Profile
5.5.2 Promega Main Business
5.5.3 Promega Custom Assays Products, Services and Solutions
5.5.4 Promega Custom Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Promega Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Custom Assays Products, Services and Solutions
5.6.4 Merck Custom Assays Revenue (US$ Million) & (2018-2023)
5.6.5 Merck Recent Developments
5.7 GE Healthcare Lifescience
5.7.1 GE Healthcare Lifescience Profile
5.7.2 GE Healthcare Lifescience Main Business
5.7.3 GE Healthcare Lifescience Custom Assays Products, Services and Solutions
5.7.4 GE Healthcare Lifescience Custom Assays Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Lifescience Recent Developments
5.8 Cisbio
5.8.1 Cisbio Profile
5.8.2 Cisbio Main Business
5.8.3 Cisbio Custom Assays Products, Services and Solutions
5.8.4 Cisbio Custom Assays Revenue (US$ Million) & (2018-2023)
5.8.5 Cisbio Recent Developments
5.9 Biosensorix
5.9.1 Biosensorix Profile
5.9.2 Biosensorix Main Business
5.9.3 Biosensorix Custom Assays Products, Services and Solutions
5.9.4 Biosensorix Custom Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Biosensorix Recent Developments
5.10 ProeoGenix
5.10.1 ProeoGenix Profile
5.10.2 ProeoGenix Main Business
5.10.3 ProeoGenix Custom Assays Products, Services and Solutions
5.10.4 ProeoGenix Custom Assays Revenue (US$ Million) & (2018-2023)
5.10.5 ProeoGenix Recent Developments
5.11 Ethos Biosciences
5.11.1 Ethos Biosciences Profile
5.11.2 Ethos Biosciences Main Business
5.11.3 Ethos Biosciences Custom Assays Products, Services and Solutions
5.11.4 Ethos Biosciences Custom Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Ethos Biosciences Recent Developments
5.12 Abzena
5.12.1 Abzena Profile
5.12.2 Abzena Main Business
5.12.3 Abzena Custom Assays Products, Services and Solutions
5.12.4 Abzena Custom Assays Revenue (US$ Million) & (2018-2023)
5.12.5 Abzena Recent Developments
5.13 Agena Bioscience
5.13.1 Agena Bioscience Profile
5.13.2 Agena Bioscience Main Business
5.13.3 Agena Bioscience Custom Assays Products, Services and Solutions
5.13.4 Agena Bioscience Custom Assays Revenue (US$ Million) & (2018-2023)
5.13.5 Agena Bioscience Recent Developments
5.14 Agilent
5.14.1 Agilent Profile
5.14.2 Agilent Main Business
5.14.3 Agilent Custom Assays Products, Services and Solutions
5.14.4 Agilent Custom Assays Revenue (US$ Million) & (2018-2023)
5.14.5 Agilent Recent Developments
5.15 TissueMetrics
5.15.1 TissueMetrics Profile
5.15.2 TissueMetrics Main Business
5.15.3 TissueMetrics Custom Assays Products, Services and Solutions
5.15.4 TissueMetrics Custom Assays Revenue (US$ Million) & (2018-2023)
5.15.5 TissueMetrics Recent Developments
5.16 Eurofins Scientific
5.16.1 Eurofins Scientific Profile
5.16.2 Eurofins Scientific Main Business
5.16.3 Eurofins Scientific Custom Assays Products, Services and Solutions
5.16.4 Eurofins Scientific Custom Assays Revenue (US$ Million) & (2018-2023)
5.16.5 Eurofins Scientific Recent Developments
5.17 BioGenes GmbH
5.17.1 BioGenes GmbH Profile
5.17.2 BioGenes GmbH Main Business
5.17.3 BioGenes GmbH Custom Assays Products, Services and Solutions
5.17.4 BioGenes GmbH Custom Assays Revenue (US$ Million) & (2018-2023)
5.17.5 BioGenes GmbH Recent Developments
5.18 Eve Technologies
5.18.1 Eve Technologies Profile
5.18.2 Eve Technologies Main Business
5.18.3 Eve Technologies Custom Assays Products, Services and Solutions
5.18.4 Eve Technologies Custom Assays Revenue (US$ Million) & (2018-2023)
5.18.5 Eve Technologies Recent Developments
5.19 Quansys Bioscience
5.19.1 Quansys Bioscience Profile
5.19.2 Quansys Bioscience Main Business
5.19.3 Quansys Bioscience Custom Assays Products, Services and Solutions
5.19.4 Quansys Bioscience Custom Assays Revenue (US$ Million) & (2018-2023)
5.19.5 Quansys Bioscience Recent Developments
6 North America
6.1 North America Custom Assays Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Custom Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Custom Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Custom Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Custom Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Custom Assays Market Dynamics
11.1 Custom Assays Industry Trends
11.2 Custom Assays Market Drivers
11.3 Custom Assays Market Challenges
11.4 Custom Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
